Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

NCT00630565 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Leukemia

Interventions

BIOLOGICAL: sargramostim
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: etoposide
PROCEDURE: bone marrow transplantation
PROCEDURE: hematopoietic stem cell transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: total-body irradiation

Sponsor

Masonic Cancer Center, University of Minnesota